Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026)
Bausch Health Companies (BHC) posted Deferred Taxes of $17.0 million for Q2 2026, down 43.33% sequentially from $30.0 million in Q1 2026, and up 140.48% YoY from $7.1 million in Q2 2025.
Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Deferred Taxes for 18 years, with the latest figure at $17.0 million in Q2 2026.
- Quarterly Deferred Taxes rose 140.48% year-over-year to $17.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $178.0 million (up 53.45% YoY) and the FY2025 annual result came in at $80.0 million, up 21.21% from the prior year.
- Deferred Taxes slipped to $17.0 million in Q2 2026 per BHC's latest filing, from $30.0 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $170.0 million in Q4 2024 and troughed at -$96.0 million in Q3 2022.
- A 5-year average of $4.0 million and a median of -$9.0 million in 2025 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2025 and 2026: Deferred Taxes sank 700.0% in 2025, then surged 433.33% in 2026.
- Over 5 years, Deferred Taxes stood at $19.0 million in 2022, then surged by 342.11% to $84.0 million in 2023, then surged by 102.38% to $170.0 million in 2024, then fell by 8.82% to $155.0 million in 2025, then tumbled by 89.03% to $17.0 million in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $17.0 million, $30.0 million, and $155.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.00 Mn |
| Mar 31, 2026 | 30.00 Mn |
| Dec 31, 2025 | 155.00 Mn |
| Sep 30, 2025 | -24.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | -9.00 Mn |
| Dec 31, 2024 | 170.00 Mn |
| Sep 30, 2024 | -3.00 Mn |
| Jun 30, 2024 | -44.00 Mn |
| Mar 31, 2024 | -57.00 Mn |
| Dec 31, 2023 | 84.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -30.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | -96.00 Mn |
| Jun 30, 2022 | -16.00 Mn |
| Mar 31, 2022 | -83.00 Mn |
| Dec 31, 2021 | -88.00 Mn |
| Sep 30, 2021 | -17.00 Mn |
| Jun 30, 2021 | -106.00 Mn |